基本信息
views: 0
![](https://originalfileserver.aminer.cn/sys/aminer/icon/show-trajectory.png)
Bio
Our team focuses on AI algorithms and software platforms for the integration of complex data in clinical genomics and drug discovery: (1) federated analysis of real-world clinical and genomic data, (2) data fusion algorithms for the identification of pathogenic genetic variation in rare genetic disorders and liquid biopsies, and (3) data fusion for drug discovery and drug design. At the algorithmic level, I focus on the development of novel AI methods, such as deep learning and Bayesian matrix factorization, for the fusion of heterogeneous sparsely-observed data; and on privacy-preserving implementations of such methods. I aim at demonstrated clinical or industrial applicability of our methods and proven effectiveness in human genetics research and drug discovery.
I am engaged in a reflection on how information technology and artificial intelligence are transforming our world and on how to make sure this transformation is beneficial for all. In particular, I am actively pushing back against the emergence of surveillance societies that has been made possible by such technological advances. For these activities, see my press portfolio.
I am also a tech innovator interested in identifying relevant business models for emerging technologies and developing projects up to the precompetitive stage and the startup of university spin-offs. I am a co-founder of Data4S, a data mining company specialized in fraud detection and anti-moneylaundering, which is now part of BAE Systems, Detica NetReveal. I am also a co-founder of Cartagenia, specialized in ICT solutions for clinical genetic diagnosis.
I am engaged in a reflection on how information technology and artificial intelligence are transforming our world and on how to make sure this transformation is beneficial for all. In particular, I am actively pushing back against the emergence of surveillance societies that has been made possible by such technological advances. For these activities, see my press portfolio.
I am also a tech innovator interested in identifying relevant business models for emerging technologies and developing projects up to the precompetitive stage and the startup of university spin-offs. I am a co-founder of Data4S, a data mining company specialized in fraud detection and anti-moneylaundering, which is now part of BAE Systems, Detica NetReveal. I am also a co-founder of Cartagenia, specialized in ICT solutions for clinical genetic diagnosis.
Research Interests
Papers共 473 篇Author StatisticsCo-AuthorSimilar Experts
By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Benjamin Huremagic, Nishkala Sattanathan, Eleonora Zucchi,Geert Vandeweyer,Yves Moreau,Joris Robert Vermeesch
EUROPEAN JOURNAL OF HUMAN GENETICS (2024): 659-660
Cited0Views0Bibtex
0
0
PLOS digital healthno. 7 (2024): e0000533-e0000533
JMIR Formative Research (2024): e55496
arxiv(2024)
Cited0Views0Bibtex
0
0
Antoine Passemiers, Stefania Tuveri, Dhanya Sudhakaran,Tatjana Jatsenko,Tina Laga, Kevin Punie, Sigrid Hatse,Sabine Tejpar, An Coosemans,Els Van Nieuwenhuysen, Dirk Timmerman, Giuseppe Floris,
Bioinformatics (Oxford, England) (2024)
APPLIED MATHEMATICS AND COMPUTATION (2024): 128377-128377
CVPR 2024 (2024)
Cited0Views0Bibtex
0
0
Scientific reportsno. 1 (2024): 13188-13188
Cited0Views0Bibtex
0
0
Load More
Author Statistics
#Papers: 463
#Citation: 28005
H-Index: 65
G-Index: 160
Sociability: 8
Diversity: 3
Activity: 41
Co-Author
Co-Institution
D-Core
- 合作者
- 学生
- 导师
Data Disclaimer
The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn